Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108558.RAVlcJtQ8pg6g0BRC6h9EmBDBHoyELXociynbW4xKbBUs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108558.RAVlcJtQ8pg6g0BRC6h9EmBDBHoyELXociynbW4xKbBUs130_assertion type Assertion NP1108558.RAVlcJtQ8pg6g0BRC6h9EmBDBHoyELXociynbW4xKbBUs130_head.
- NP1108558.RAVlcJtQ8pg6g0BRC6h9EmBDBHoyELXociynbW4xKbBUs130_assertion description "[For example, in indolent CLL, 13q14 deletions targeting miR-15/16 initiate the disease, while in aggressive CLL miR-181 targets the critical TCL1 oncogene and can also be used as a progression marker.Here we discuss the foremost findings about the role of microRNAs in CLL pathogenesis, and how this knowledge can be used to identify new approaches to treat CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108558.RAVlcJtQ8pg6g0BRC6h9EmBDBHoyELXociynbW4xKbBUs130_provenance.
- NP1108558.RAVlcJtQ8pg6g0BRC6h9EmBDBHoyELXociynbW4xKbBUs130_assertion evidence source_evidence_literature NP1108558.RAVlcJtQ8pg6g0BRC6h9EmBDBHoyELXociynbW4xKbBUs130_provenance.
- NP1108558.RAVlcJtQ8pg6g0BRC6h9EmBDBHoyELXociynbW4xKbBUs130_assertion SIO_000772 24014303 NP1108558.RAVlcJtQ8pg6g0BRC6h9EmBDBHoyELXociynbW4xKbBUs130_provenance.
- NP1108558.RAVlcJtQ8pg6g0BRC6h9EmBDBHoyELXociynbW4xKbBUs130_assertion wasDerivedFrom befree-2016 NP1108558.RAVlcJtQ8pg6g0BRC6h9EmBDBHoyELXociynbW4xKbBUs130_provenance.
- NP1108558.RAVlcJtQ8pg6g0BRC6h9EmBDBHoyELXociynbW4xKbBUs130_assertion wasGeneratedBy ECO_0000203 NP1108558.RAVlcJtQ8pg6g0BRC6h9EmBDBHoyELXociynbW4xKbBUs130_provenance.